Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49377| Title: | The impact of the medicinal products identifier on wholesale distribution |
| Authors: | Miceli, Cristina Serracino-Inglott, Anthony |
| Keywords: | Pharmaceutical industry -- Quality control Pharmaceutical technology -- Standards -- European Union countries Drugs -- Safety measures -- Malta Drugs -- Law and legislation -- Malta |
| Issue Date: | 2018-09 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Miceli, C., & Serracino Inglott, A. (2018, September). The impact of the medicinal products identifier on wholesale distribution. Poster session presented at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Glasgow, United Kingdom. |
| Abstract: | A poster presentation regarding the impact of the medicinal products identifier on wholesale distribution. Introduction: The European Union issued the Falsified Medicines Directive (FMD), to protect the legal supply chain of medicinal products. The Falsified Medicines Directive enables stakeholders to verify the authenticity of a medicinal product through the use of a Unique Identifier for each unit pack. Aims: To assess the impact the Unique Identifer will have on the wholesale distribution of medicinal products. To identify and review requirements set out by the Falsified Medicines Directive. To identify 3 scenarios faced by wholesale distributors. To write SOPs for each scenario chosen to show how the directive can be implemented in a practical setting. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/49377 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| The_impact_of_the_medicinal_products_identifier_on_wholesale_distribution_2018.pdf | 547.15 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.